FDA approves gene-editing treatment for sickle cell disease

Will FDA crackdown on lab tests protect patients—or limit access to care?

The first CRISPR therapy approved in the U.S. will treat sickle cell disease

FDA approves world's first CRISPR gene-editing drug for sickle cell disease